May 10 (Reuters) - Xanodyne Pharmaceuticals Inc: * Ferring acquires Lysteda(TM) from Xanodyne Pharmaceuticals Inc * Ferring Pharmaceuticals says global acquisition expands Ferring's role in Women's Health * Ferring will initially market Lysteda in the U.S., and is evaluating opportunities in other markets ((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780)) (For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved.
The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.